FCCL supplier Taiflex Scientific expects its revenues to grow 10.5% sequentially and 2.2% on year to NT$2.6-3.3 billion (US$86.78-110.14 million) in the third quarter of 2014, with a gross margin of 21-25% and operating margin of 11-15%.
from DIGITIMES: IT news from Asia http://ift.tt/1ztZI5p
via Yuichun
from DIGITIMES: IT news from Asia http://ift.tt/1ztZI5p
via Yuichun
沒有留言:
張貼留言